Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tepper

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Biomedical Imaging|December 19, 2013
Comparison of User-Directed and Automatic Mapping of the Planned Isocenter to Treatment Space for Prostate IGRTZijie Xu, Ronald Chen, Andrew Wang, et al.
Disaster Medicine and Public Health Preparedness|March 24, 2026
Overcoming Cancer Disparities Globally: Contributions of Norman ColemanDavid Pistenmaa, Joel Tepper, Donna O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)Neal J Meropol, Donna Niedzwiecki, Brenda Shank, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell CarcinomaBhishamjit S Chera, Robert J Amdur, Joel Tepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingMelanie B Thomas, Deborah Jaffe, Michael M Choti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancerStephen M Hahn, Eric J Bernhard, William Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatmentPhilip A Philip, Margaret Mooney, Deborah Jaffe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2005
The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European ConsensusVincenzo Valentini, Bengt Glimelius, Bruce D Minsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative GroupsPeter J O'Dwyer, S Gail Eckhardt, Daniel G Haller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancerNeil E Martin, Thomas B Brunner, Krystina D Kiel, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Biomedical Imaging|December 19, 2013
Comparison of User-Directed and Automatic Mapping of the Planned Isocenter to Treatment Space for Prostate IGRTZijie Xu, Ronald Chen, Andrew Wang, et al.
Disaster Medicine and Public Health Preparedness|March 24, 2026
Overcoming Cancer Disparities Globally: Contributions of Norman ColemanDavid Pistenmaa, Joel Tepper, Donna O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)Neal J Meropol, Donna Niedzwiecki, Brenda Shank, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell CarcinomaBhishamjit S Chera, Robert J Amdur, Joel Tepper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning MeetingMelanie B Thomas, Deborah Jaffe, Michael M Choti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancerStephen M Hahn, Eric J Bernhard, William Regine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatmentPhilip A Philip, Margaret Mooney, Deborah Jaffe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2005
The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European ConsensusVincenzo Valentini, Bengt Glimelius, Bruce D Minsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative GroupsPeter J O'Dwyer, S Gail Eckhardt, Daniel G Haller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancerNeil E Martin, Thomas B Brunner, Krystina D Kiel, et al.
Pageof 3